Lilly Industries Limited
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lilly Industries Limited.The latest application filed is for "pharmaceutical compounds".
- Lilly Industries Limited - Basingstoke GB2
- Lilly Industries Limited - Hampshire GB2
- Lilly Industries Limited - London GB2
- Lilly Industries, Ltd. - London GB2
- Lilly Industries, Ltd. - EN EN
| Patent | Date |
|---|---|
| Pharmaceutical compounds Grant 5,663,375 - Brunavs , et al. September 2, 1 | 1997-09-02 |
| Solvate of olanzapine Grant 5,637,584 - Larsen June 10, 1 | 1997-06-10 |
| 2-methyl-thieno-benzodiazepine Grant 5,627,178 - Chakrabarti , et al. May 6, 1 | 1997-05-06 |
| 2-methyl-thieno-benzodiazepine Grant 5,605,897 - Beasley, Jr. , et al. February 25, 1 | 1997-02-25 |
| Pyrano[3,2-h]quinolines for treating restenosis Grant 5,434,160 - Dell , et al. July 18, 1 | 1995-07-18 |
| Pharmaceutical compounds Grant 5,410,061 - Gilmore , et al. April 25, 1 | 1995-04-25 |
| Pharmaceutical compounds Grant 5,284,868 - Dell , et al. February 8, 1 | 1994-02-08 |
| 2-methyl-thieno-benzodiazepine Grant 5,229,382 - Chakrabarti , et al. July 20, 1 | 1993-07-20 |
| Pharmaceutical compounds Grant 5,158,971 - Clarke , et al. October 27, 1 | 1992-10-27 |
| Pyrazolo-[3,4-g]isoquinoline derivatives useful to treat CNS disorders Grant 4,963,558 - Hotten , et al. October 16, 1 | 1990-10-16 |
| Capsules Grant 4,892,766 - Jones January 9, 1 | 1990-01-09 |
| Capsules Grant 4,822,618 - Schweiger , et al. April 18, 1 | 1989-04-18 |
| Chewable capsules Grant 4,755,389 - Jones , et al. July 5, 1 | 1988-07-05 |
| Bifunctional ester derivatives of 4-desacetyl indole-dihydroindole alkaloids Grant 4,596,676 - Cullinan June 24, 1 | 1986-06-24 |
| Method of treating hypersensitivity disease with benzoxazole derivatives Grant 4,416,892 - Dawson November 22, 1 | 1983-11-22 |
| Pyrazolo [3,4-b][1,5]benzodiazepine compounds Grant 4,404,137 - Chakrabarti , et al. September 13, 1 | 1983-09-13 |
| Medicinal tablet Grant D267,122 - Scotton , et al. November 30, 1 | 1982-11-30 |
| Treatment of immediate hypersensitivity diseases with aryl hydantoins Grant 4,241,073 - Jamieson , et al. December 23, 1 | 1980-12-23 |
| Cephalexin tablets Grant 4,143,129 - Marsden March 6, 1 | 1979-03-06 |
| Bottle Grant D249,866 - Felix October 10, 1 | 1978-10-10 |
| Thieno[3,2-b]-[1,5]benzodiazepines Grant 4,115,568 - Chakrabarti , et al. September 19, 1 | 1978-09-19 |
| Benzodiazepine derivatives Grant 4,115,574 - Chakrabarti , et al. September 19, 1 | 1978-09-19 |
| Benzoxazole derivatives Grant RE29,608 - Evans , et al. April 11, 1 | 1978-04-11 |
| 2,5 OR 2,6 Disubstituted benzoxazoles Grant 4,025,637 - Dunwell , et al. May 24, 1 | 1977-05-24 |
| Preparation of .alpha.-acetoxy aldehydes and ketones Grant 3,965,157 - Harrison June 22, 1 | 1976-06-22 |
| Production of capsules Grant 3,927,195 - Messora December 16, 1 | 1975-12-16 |
| Benzoxazole derivatives Grant 3,912,748 - Evans , et al. October 14, 1 | 1975-10-14 |
| Drug Formulations Grant 3,859,431 - Newton , et al. January 7, 1 | 1975-01-07 |
| An Apparatus For Making Spherical Granules Grant 3,741,703 - Reynolds June 26, 1 | 1973-06-26 |
| Anti-inflammatory Method Grant 3,674,871 - Evans July 4, 1 | 1972-07-04 |
| NCAGE Code | K5492 | LILLY INDUSTRIES LIMITED |
| CAGE Code | K5492 | LILLY INDUSTRIES LIMITED |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 